Clinical Trials Browser

Phase 2 × Multiple Myeloma × propranolol CR × Clear all

NCT02420223 2021-06-07

Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients

Phase 2 Completed

25 enrolled 15 charts

Multiple Myeloma